Skip to main content

Elanco Animal Health Inc

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

ELAN$26.84+4.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 2. RESULTS OF OPERATIONS

Results of Operations

The following discussion and analysis of our results of operations should be read along with our condensed consolidated financial statements and the notes thereto. Our results of operations for the periods presented below may not be comparable with prior periods or with our results of operations in the future due to many factors, including but not limited to the factors identified above.

Three Months Ended September 30,Nine Months Ended September 30,
(Dollars in millions)20252024% Change20252024% Change
Revenue$1,137$1,03010%$3,571$3,4194%
Cost of sales5304928%1,5671,5024%
Gross profit60753813%2,0041,9175%
Research and development89872%2752635%
Marketing, selling and administrative3513239%1,0921,0148%
Amortization of intangible assets1401335%4043972%
Asset impairment, restructuring and other special charges251747%35143(76)%
Gain on divestiture—(640)NM—(640)NM
Interest expense, net of capitalized interest5258(10)%140189(26)%
Other expense, net—1NM231292%
(Loss) income before income taxes(50)559NM35539(94)%
Income tax (benefit) expense(16)195NM(9)193NM
Net (loss) income$(34)$364NM$44$346(87)%

Certain amounts and percentages may reflect rounding adjustments.

NM - Not meaningful

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.